Harvard Bioscience (HBIO) Profit After Tax (2010 - 2026)
Harvard Bioscience (HBIO) reported Profit After Tax of -$3.4 million for Q1 2026, up 93.2% year-over-year from -$1.8 million in Q1 2025, and down 20.27% quarter-over-quarter from -$2.8 million in Q4 2025.
Harvard Bioscience (HBIO) Profit After Tax (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of Profit After Tax data on file, last reported at -$3.4 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$3.4 million, up 93.2% year-over-year; the trailing twelve-month figure through Mar 2026 was -$9.8 million (up 83.15% YoY), and the FY2025 annual result was -$56.7 million, down 357.07% from the prior year.
- Profit After Tax declined to -$3.4 million in Q1 2026 per HBIO's latest filing, from -$2.8 million in the prior quarter.
- Over five years, Profit After Tax peaked at $2.4 million in Q2 2022 and troughed at -$50.3 million in Q1 2025.
- A 5-year average of -$5.0 million and a median of -$2.3 million in 2025 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax surged 693.9% in 2022, then slumped 15916.67% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$1.7 million in 2022, then decreased by 9.12% to -$1.8 million in 2023, then soared by 100.99% to $18000.0 in 2024, then tumbled by 15916.67% to -$2.8 million in 2025, then declined by 20.27% to -$3.4 million in 2026.
- Business Quant data shows HBIO's Profit After Tax at -$3.4 million in Q1 2026, -$2.8 million in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 821.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 138.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -3.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.42 Mn |
| Dec 31, 2025 | -2.85 Mn |
| Sep 30, 2025 | -1.23 Mn |
| Jun 30, 2025 | -2.28 Mn |
| Mar 31, 2025 | -50.34 Mn |
| Dec 31, 2024 | 18,000.00 |
| Sep 30, 2024 | -4.80 Mn |
| Jun 30, 2024 | -2.93 Mn |
| Mar 31, 2024 | -4.69 Mn |
| Dec 31, 2023 | -1.82 Mn |
| Sep 30, 2023 | -1.24 Mn |
| Jun 30, 2023 | -980,000.00 |
| Mar 31, 2023 | 622,000.00 |
| Dec 31, 2022 | -1.67 Mn |
| Sep 30, 2022 | -3.41 Mn |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | -6.88 Mn |
| Dec 31, 2021 | 961,000.00 |
| Sep 30, 2021 | -170,000.00 |
| Jun 30, 2021 | -410,000.00 |